Moderna, at its annual R&D Day, updated progress on its Covid-19 vaccine and drug pipeline, and said it would work to develop a seasonal flu vaccine; MRNA stock looked to continue its win streak.

The post Moderna Updates Progress On Covid-19 Vaccine, Eyes Flu Vaccine appeared first on Investor's Business Daily.